Cargando…

The AAV-PCSK9 murine model of atherosclerosis and metabolic dysfunction

AIMS: Mouse models with genetic modifications are required to investigate atherogenesis and associated metabolic syndrome. Adeno-associated virus-8 (AAV8)-mediated overexpression of PCSK9 (AAV8-PCSK9) induces hyperlipidaemia and promotes atherosclerosis in C57BL/6 mice. We aimed to assess whether AA...

Descripción completa

Detalles Bibliográficos
Autores principales: Keeter, William Coles, Carter, Nigeste M, Nadler, Jerry L, Galkina, Elena V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242032/
https://www.ncbi.nlm.nih.gov/pubmed/35919346
http://dx.doi.org/10.1093/ehjopen/oeac028
_version_ 1784737965309689856
author Keeter, William Coles
Carter, Nigeste M
Nadler, Jerry L
Galkina, Elena V
author_facet Keeter, William Coles
Carter, Nigeste M
Nadler, Jerry L
Galkina, Elena V
author_sort Keeter, William Coles
collection PubMed
description AIMS: Mouse models with genetic modifications are required to investigate atherogenesis and associated metabolic syndrome. Adeno-associated virus-8 (AAV8)-mediated overexpression of PCSK9 (AAV8-PCSK9) induces hyperlipidaemia and promotes atherosclerosis in C57BL/6 mice. We aimed to assess whether AAV8-PCSK9-injected C57BL/6 mice fed high-fat diet with added cholesterol (HFD-C) would serve as a model of combined metabolic syndrome and atherosclerosis. METHODS AND RESULTS: C57BL/6 mice received i.v. injection of AAV-PCSK9 and sex- and age-matched Ldlr(−/−) and C57BL/6 control mice were placed on HFD-C or chow diet for 20 weeks (B6-PCSK9-HFD-C, Ldlr(−/−) HFD-C, B6-HFD-C, and B6-Chow, respectively). High-fat diet with added cholesterol feeding led to insulin resistance and impaired glucose clearance in B6-PCSK9-HFD-C mice compared with B6-Chow controls. This decrease in metabolic health in B6-PCSK9-HFD-C mice as well as the development of atherosclerosis was similar to Ldlr(−/−) HFD-C mice. Importantly, HFD-C feeding induced pancreatic islet hyperplasia in B6-PCSK9-HFD-C and B6-HFD-C compared with B6-Chow controls. In line with alterations in the metabolic phenotype, there was an increase in the number of pro-inflammatory Ly6C(high/med) monocytes within the adipose tissues of B6-PCSK9-HFD-C and B6-HFD-C compared with B6-Chow controls. CONCLUSION: High-fat diet with added cholesterol-fed AAV-PCSK9-injected C57BL/6 mice can serve as a useful model of integrated metabolic syndrome and atherosclerosis that does not require genetic manipulations.
format Online
Article
Text
id pubmed-9242032
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-92420322022-08-01 The AAV-PCSK9 murine model of atherosclerosis and metabolic dysfunction Keeter, William Coles Carter, Nigeste M Nadler, Jerry L Galkina, Elena V Eur Heart J Open Short Report AIMS: Mouse models with genetic modifications are required to investigate atherogenesis and associated metabolic syndrome. Adeno-associated virus-8 (AAV8)-mediated overexpression of PCSK9 (AAV8-PCSK9) induces hyperlipidaemia and promotes atherosclerosis in C57BL/6 mice. We aimed to assess whether AAV8-PCSK9-injected C57BL/6 mice fed high-fat diet with added cholesterol (HFD-C) would serve as a model of combined metabolic syndrome and atherosclerosis. METHODS AND RESULTS: C57BL/6 mice received i.v. injection of AAV-PCSK9 and sex- and age-matched Ldlr(−/−) and C57BL/6 control mice were placed on HFD-C or chow diet for 20 weeks (B6-PCSK9-HFD-C, Ldlr(−/−) HFD-C, B6-HFD-C, and B6-Chow, respectively). High-fat diet with added cholesterol feeding led to insulin resistance and impaired glucose clearance in B6-PCSK9-HFD-C mice compared with B6-Chow controls. This decrease in metabolic health in B6-PCSK9-HFD-C mice as well as the development of atherosclerosis was similar to Ldlr(−/−) HFD-C mice. Importantly, HFD-C feeding induced pancreatic islet hyperplasia in B6-PCSK9-HFD-C and B6-HFD-C compared with B6-Chow controls. In line with alterations in the metabolic phenotype, there was an increase in the number of pro-inflammatory Ly6C(high/med) monocytes within the adipose tissues of B6-PCSK9-HFD-C and B6-HFD-C compared with B6-Chow controls. CONCLUSION: High-fat diet with added cholesterol-fed AAV-PCSK9-injected C57BL/6 mice can serve as a useful model of integrated metabolic syndrome and atherosclerosis that does not require genetic manipulations. Oxford University Press 2022-04-20 /pmc/articles/PMC9242032/ /pubmed/35919346 http://dx.doi.org/10.1093/ehjopen/oeac028 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Short Report
Keeter, William Coles
Carter, Nigeste M
Nadler, Jerry L
Galkina, Elena V
The AAV-PCSK9 murine model of atherosclerosis and metabolic dysfunction
title The AAV-PCSK9 murine model of atherosclerosis and metabolic dysfunction
title_full The AAV-PCSK9 murine model of atherosclerosis and metabolic dysfunction
title_fullStr The AAV-PCSK9 murine model of atherosclerosis and metabolic dysfunction
title_full_unstemmed The AAV-PCSK9 murine model of atherosclerosis and metabolic dysfunction
title_short The AAV-PCSK9 murine model of atherosclerosis and metabolic dysfunction
title_sort aav-pcsk9 murine model of atherosclerosis and metabolic dysfunction
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242032/
https://www.ncbi.nlm.nih.gov/pubmed/35919346
http://dx.doi.org/10.1093/ehjopen/oeac028
work_keys_str_mv AT keeterwilliamcoles theaavpcsk9murinemodelofatherosclerosisandmetabolicdysfunction
AT carternigestem theaavpcsk9murinemodelofatherosclerosisandmetabolicdysfunction
AT nadlerjerryl theaavpcsk9murinemodelofatherosclerosisandmetabolicdysfunction
AT galkinaelenav theaavpcsk9murinemodelofatherosclerosisandmetabolicdysfunction
AT keeterwilliamcoles aavpcsk9murinemodelofatherosclerosisandmetabolicdysfunction
AT carternigestem aavpcsk9murinemodelofatherosclerosisandmetabolicdysfunction
AT nadlerjerryl aavpcsk9murinemodelofatherosclerosisandmetabolicdysfunction
AT galkinaelenav aavpcsk9murinemodelofatherosclerosisandmetabolicdysfunction